The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpringfield Pr. Regulatory News (SPR)

Share Price Information for Springfield Pr. (SPR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 94.00
Bid: 93.00
Ask: 95.00
Change: 0.00 (0.00%)
Spread: 2.00 (2.151%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 94.00
SPR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of Chief Financial Officer

12 Jul 2023 07:00

RNS Number : 7149F
Springfield Properties PLC
12 July 2023
 

12 July 2023

 

Springfield Properties plc

("Springfield", the "Company", the "Group" or the "Springfield Group")

 

Appointment of Chief Financial Officer

 

Springfield Properties plc (AIM: SPR), a leading housebuilder in Scotland focused on delivering private and affordable housing, is pleased to announce the appointment of Iain Logan as Chief Financial Officer ("CFO") of the Company.

 

Mr. Logan, aged 49, has served as interim CFO of the Company since 13 March 2023 having previously held the positions of Finance Director and Group Financial Controller over the last three years. In these roles, Mr. Logan was responsible for leading all aspects of financial operations and reporting and for managing the Group's banking relationships. He also played a key role in the Company's acquisition, and integration, of Tulloch Homes in December 2021 and the Scottish housebuilding division of MacTaggart & Mickel in June 2022.

 

Prior to joining Springfield, Mr. Logan was Group Financial Controller of AIM-quoted Omega Diagnostics Group plc, a specialist medical diagnostics company, for nine years. During this time, his role included being responsible for the external financial reporting of the business and management of finance teams in the UK, Germany and India. Mr. Logan joined Omega Diagnostics after spending eight years with Murray International Holdings Limited where he gained extensive corporate finance experience working on all aspects of acquisitions, disposals and fundraising within its investment company. He also held the Financial Controller role for its residential and property development company. He is a Chartered Accountant with the Institute of Chartered Accountants of Scotland and began his career at PwC in Edinburgh.

 

Mr. Logan will be appointed to the Board of the Company subject to the completion of the requisite regulatory due diligence by the Company's Nomad. The Company will update the market in due course and provide any information that is required to be disclosed pursuant to paragraph (g) of Schedule 2 of the AIM Rules.

 

Innes Smith, CEO of Springfield, said: "The Board has been very pleased with Iain's performance following his appointment as interim CFO and unanimously decided to make the position permanent. Since joining Springfield over three years ago, Iain has made an important contribution to our finance function and, increasingly, across the business. Accordingly, this appointment is in-keeping with our long-held values of supporting the development of our people and providing them with the opportunity to grow. We look forward to continuing to benefit from Iain's knowledge of the Group's operations and his broader experience, and to welcoming him to the Board in due course."

 

Enquiries:

 

Springfield Properties

Sandy Adam, Chairman

Innes Smith, Chief Executive Officer

+44 1343 552550

Singer Capital Markets

Shaun Dobson, James Moat, Oliver Platts (Investment Banking)

+44 20 7496 3000

Gracechurch Group

Harry Chathli, Claire Norbury

+44 20 4582 3500

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOADGGDRUUBDGXB
Date   Source Headline
8th Apr 202411:25 amRNSBlock Listing Application
20th Mar 20242:58 pmRNSExercise of Options, Issue of Equity and TVR
29th Feb 20245:12 pmRNSDirector Share Purchase
20th Feb 20248:14 amRNSProgressive publish new research
20th Feb 20247:00 amRNSInterim Results
19th Feb 20247:00 amRNSSale of land for £8.7m
6th Feb 20247:00 amRNSSpringfield signs £15m affordable housing contract
2nd Feb 20241:45 pmRNSBlock listing Interim Review
30th Jan 20247:00 amRNSNotice of Results
26th Jan 20242:59 pmRNSExercise of Options, Issue of Equity and TVR
19th Jan 20247:00 amRNSExercise of Options, Issue of Equity and TVR
15th Jan 20246:06 pmRNSExercise of Options, Issue of Equity and TVR
3rd Jan 20241:01 pmRNSExercise of Options, Issue of Equity and TVR
13th Dec 20238:01 amRNSProgressive publishes new research
13th Dec 20237:00 amRNSTrading Update
4th Dec 20237:00 amRNSSale of land for £4.2 million
14th Nov 20234:07 pmRNSExercise of Options, Issue of Equity and TVR
8th Nov 20235:36 pmRNSExercise of Options, Issue of Equity and TVR
6th Nov 20237:00 amRNSSpringfield signs £6m affordable housing contract
1st Nov 20239:44 amRNSGrant of performance share awards
1st Nov 20237:00 amRNSDirectorate Change
26th Oct 20237:00 amRNSResult of AGM
16th Oct 20237:00 amRNSSale of land for £5.2 million
28th Sep 20233:45 pmRNSNotice of Annual General Meeting
20th Sep 202312:37 pmRNSFinal Results and Publication of Annual Report
1st Sep 20233:30 pmRNSExercise of Options, Issue of Equity and TVR
29th Aug 202310:09 amRNSExercise of Options, Issue of Equity and TVR
27th Jul 20233:19 pmRNSDirector Shareholding, Issue of Equity and TVR
26th Jul 202310:06 amRNSAIM Rules Schedule 2(g) Notification
24th Jul 20239:26 amRNSHolding(s) in Company
19th Jul 20238:00 amRNSInitiation of research coverage
19th Jul 20237:00 amRNSTrading Update
12th Jul 20237:00 amRNSAppointment of Chief Financial Officer
12th Apr 20235:35 pmRNSDirector Shareholding
31st Mar 20231:45 pmRNSDirector Shareholding
13th Mar 20237:00 amRNSDirectorate Change
24th Feb 20235:03 pmRNSDirector Shareholdings
21st Feb 20237:00 amRNSInterim Results
8th Feb 20237:00 amRNSNotice of Results
2nd Feb 202311:24 amRNSTotal Voting Rights
23rd Jan 20239:36 amRNSDirector Shareholding, Issue of Equity and TVR
21st Dec 202211:03 amRNSDirector Share Purchases
19th Dec 20225:14 pmRNSDirector Share Purchases
14th Dec 20221:23 pmRNSDirector Share Purchase
12th Dec 20229:05 amRNSSecond Price Monitoring Extn
12th Dec 20229:00 amRNSPrice Monitoring Extension
12th Dec 20227:00 amRNSTrading Update
23rd Nov 20227:00 amRNSSpringfield awarded best sustainable development
31st Oct 202212:48 pmRNSResult of AGM
21st Sep 20221:10 pmRNSNotice of Annual General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.